| Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 3 Feb 25 | ETNB 89bio | Stock Option Common Stock | Grant | Acquire A | No | No | 9.6 | 56,400 | 541.44 k | 56,400 |
| 20 Jun 24 | ACRV Acrivon Therapeutics, Inc. Common Stock | Stock Option Common Stock | Grant | Acquire A | No | No | 6.52 | 20,275 | 132.19 k | 20,275 |
| 24 May 24 | HOWL Werewolf Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 4.88 | 17,500 | 85.40 k | 17,500 |
| 22 May 24 | MLYS Mineralys Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 12.52 | 22,000 | 275.44 k | 22,000 |
| 1 Feb 24 | ETNB 89bio | Stock Option Common Stock | Grant | Acquire A | No | No | 9.98 | 45,150 | 450.60 k | 45,150 |
